trial · primary record
ASTX727
MDS/MPN
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 94 |
| Primary completion | 2027-12 |
| Primary endpoint | Phase 1: Determination of dose |
| Registry ID | NCT04061421 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:49.236Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04061421
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.